18F-FDG PET/MRI用于胆管内乳头状肿瘤无创风险分层
这项回顾性研究纳入8例病理确诊IPNB患者的10个病灶,评估18F-FDG PET/MRI评估生物学侵袭性的价值。SUVmax及病灶/肝脏SUVmax比值与组织学分级正相关,比值在伴浸润性腺癌者中更高,ROC分析AUC为0.90-0.96。PET/MRI有望用于术前风险分层,但需更大前瞻性研究验证。
要点
- 病灶/肝脏SUVmax比值与组织学分级相关性最强(ρ=0.844)。
- 伴浸润性腺癌者SUVmax比值高于非腺癌及异型增生病灶。
- SUVmax截断值8.04、比值3.00时敏感度80%、特异度100%。
核心结论
- 杂交18F-FDG PET/MRI在IPNB术前评估和风险分层方面显示出有前景的潜力,值得在更大规模前瞻性研究中验证。
研究设计与样本
- 回顾性研究纳入8例病理确诊IPNB患者(5男3女,中位年龄65.5岁)共10个病灶,分析18F-FDG摄取、强化、弥散受限、管壁浸润、病灶大小、SUVmax及病灶/肝脏SUVmax比值。
- 最终病灶分类基于整合病理与影像随访的复合参考标准,以考虑活检采样误差。
主要发现
- 10个病灶中5个为IPNB伴浸润性腺癌、4个为异型增生、1个为非异型增生。
- SUVmax与组织学分级正相关(ρ=0.784,p=0.007),病灶/肝脏SUVmax比值与组织学分级正相关(ρ=0.844,p=0.002)。
- 伴浸润性腺癌的IPNB中SUVmax比值高于非腺癌(p=0.016)和异型增生病灶(p=0.032)。
- 伴浸润性腺癌的IPNB中病灶SUVmax仅高于非腺癌(p=0.032),与异型增生病灶比较未达显著(p=0.063)。
关键数值与推荐
- ROC分析显示SUV参数诊断伴浸润性腺癌IPNB的AUC为0.90-0.96(95%CI 0.674-1.000)。
- SUVmax截断值8.04和SUVmax比值截断值3.00达到80%敏感度和100%特异度。
临床怎么用
- 对于病理确诊或疑似IPNB患者,术前18F-FDG PET/MRI的SUV参数(尤其病灶/肝脏SUVmax比值)可辅助无创风险分层,提示是否伴浸润性腺癌。
- SUVmax比值可能帮助克服活检采样误差的局限,辅助手术规划。
局限性
- 回顾性设计且样本量小(8例患者、10个病灶),结论需更大前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the value of hybrid 18F-FDG PET/MRI in assessing the biological aggressiveness of intraductal papillary neoplasms of the bile duct (IPNBs). METHODS: This retrospective study included patients with pathologically confirmed IPNB who underwent 18F-FDG PET/MRI. Imaging features analyzed included 18F-FDG uptake, enhancement, diffusion restriction, duct walls infiltration, lesion size, SUVmax and lesion-to-liver SUVmax ratio. Final lesion classification was based on a composite reference standard integrating pathology with imaging follow-up, to account for potential biopsy sampling error. Spearman's correlation assessed associations between SUV parameters and histological grade. Group comparisons used the Mann-Whitney U test and Fisher's exact test. ROC analysis evaluated SUV parameters in diagnosing IPNBs with associated invasive adenocarcinoma. RESULTS: Eight patients (5 M, 3 F; median age: 65.5) with 10 lesions were included: five IPNBs with associated invasive adenocarcinoma, four dysplastic, and one non-dysplastic lesion. SUVmax and lesion-to-liver SUVmax ratio positively correlated with histological grade (ρ = 0.784, p = 0.007 and ρ = 0.844, p = 0.002, respectively). SUVmax ratio was higher in IPNBs with associated invasive adenocarcinoma versus both non-adenocarcinoma (p = 0.016) and dysplastic lesions (p = 0.032). Lesion SUVmax was higher in IPNBs with associated invasive adenocarcinoma only versus non-adenocarcinoma (p = 0.032) without reaching significance against dysplastic lesions (p = 0.063). ROC analysis yielded AUC values of 0.90-0.96 (95% CI 0.674-1.000) for SUV parameters. Cut-offs of 8.04 for SUVmax and 3.00 for SUVmax ratio achieved 80% sensitivity and 100% specificity. CONCLUSION: Hybrid 18F-FDG PET/MRI shows promising potential for preoperative assessment and risk stratification of IPNBs, warranting validation in larger prospective studies. KEY POINTS: • Preoperative differentiation between dysplastic and IPNBs with invasive adenocarcinoma remains challenging, yet critical for surgical planning and prognosis. • 18F-FDG PET/MRI SUV parameters correlate with histological grade, with the lesion-to-liver SUVmax ratio showing the strongest and most robust association. • 18F-FDG PET/MRI may support non-invasive risk stratification of IPNBs, potentially overcoming the limitations associated with biopsy sampling.
引用
- Blandino AA, Quiros E, Asmundo L, et al. 18F-FDG PET/MRI for non-invasive risk stratification of Intraductal Papillary Neoplasms of the Bile Duct (IPNB). Eur J Nucl Med Mol Imaging. 2026. PMID: 42414675. doi:10.1007/s00259-026-08043-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。